| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Biomolecules & Therapeutics |
2024―Dec―27 |
Erratum to "Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein" [Biomol Ther 30(5), 427-434 (2022)] |
Jinsoo Kim, Seok Young Hwang, Dongbum Kim, Minyoung Kim, Kyeongbin Baek, Mijeong Kang, et al. (+7) Seungchan An, Junpyo Gong, Sangkyu Park, Mahmoud Kandeel, Younghee Lee, Minsoo Noh, Hyung-Joo Kwon |
| 2 |
[GO] |
Biomolecules & Therapeutics |
2024―Jun―05 |
Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model |
Bo Min Kang, Dongbum Kim, Jinsoo Kim, Kyeongbin Baek, Sangkyu Park, Ha-Eun Shin, et al. (+5) Myeong-Heon Lee, Minyoung Kim, Suyeon Kim, Younghee Lee, Hyung-Joo Kwon |
| 3 |
[GO] |
Biomolecules & Therapeutics |
2024―Feb―28 |
Erratum to "Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers" [Biomol Ther 28(4), 311-319 (2020)] |
Mahmoud Kandeel, Mizuki Yamamoto, Abdulla Al-Taher, Aya Watanabe, Kentaro Oh-hashi, Byoung Kwon Park, et al. (+3) Hyung-Joo Kwon, Jun-ichiro Inoue, Mohammed Al-Nazawi |
| 4 |
[GO] |
Biomolecules & Therapeutics |
2022―May―12 |
Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein |
Jinsoo Kim, Seok Young Hwang, Dongbum Kim, Minyoung Kim, Kyeongbin Baek, Mijeong Kang, et al. (+7) Seungchan An, Junpyo Gong, Sangkyu Park, Mahmoud Kandeel, Younghee Lee, Minsoo Noh, Hyung-Joo Kwon |
| 5 |
[GO] |
Biomolecules & Therapeutics |
2021―Oct―07 |
Small Molecule Drug Candidates for Managing the Clinical Symptoms of COVID-19: a Narrative Review |
Chawon Yun, Hyun Jae Lee, Choong Jae Lee |
| 6 |
[GO] |
Biomolecules & Therapeutics |
2021―Apr―20 |
Multifactorial Traits of SARS-CoV-2 Cell Entry Related to Diverse Host Proteases and Proteins |
Jaehwan You, Jong Hyeon Seok, Myungsoo Joo, Joon-Yong Bae, Jin Il Kim, Man-Seong Park, Kisoon Kim |
| 7 |
[GO] |
Biomolecules & Therapeutics |
2021―Mar―18 |
Antiviral Efficacy of Pralatrexate against SARS-CoV-2 |
Joon-Yong Bae, Gee Eun Lee, Heedo Park, Juyoung Cho, Jeonghun Kim, Jungmin Lee, et al. (+3) Kisoon Kim, Jin Il Kim, Man-Seong Park |
| 8 |
[GO] |
Biomolecules & Therapeutics |
2021―Jan―28 |
Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection |
Byoung Kwon Park, Dongbum Kim, Sangkyu Park, Sony Maharjan, Jinsoo Kim, Jun-Kyu Choi, et al. (+3) Madhav Akauliya, Younghee Lee, Hyung-Joo Kwon |
| 9 |
[GO] |
Biomolecules & Therapeutics |
2021―Jan―11 |
Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit |
Mahmoud Kandeel, Mizuki Yamamoto, Hideki Tani, Ayako Kobayashi, Jin Gohda, Yasushi Kawaguchi, et al. (+4) Byoung Kwon Park, Hyung-Joo Kwon, Jun-ichiro Inoue, Abdallah Alkattan |
| 10 |
[GO] |
Biomolecules & Therapeutics |
2020―Dec―29 |
COVID-19 Vaccine: Critical Questions with Complicated Answers |
Mohammad Faisal Haidere, Zubair Ahmed Ratan, Senjuti Nowroz, Sojib Bin Zaman, You-Jung Jung, Hassan Hosseinzadeh, Jae Youl Cho |
| 11 |
[GO] |
Biomolecules & Therapeutics |
2020―Mar―04 |
Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers |
Mahmoud Kandeel, Mizuki Yamamoto, Abdulla Al-Taher, Aya Watanabe, Kentaro Oh-hashi, Byoung Kwon Park, et al. (+3) Hyung-Joo Kwon, Jun-ichiro Inoue, Mohammed Al-Nazawi |
|
